Luke Gelinas, PhD

Senior IRB Chair Director, Advarra

Luke Gelinas is the Senior IRB Chair Director at Advarra, where he provides analysis and guidance on complex ethical issues arising in the course of clinical research study design and human participant protection. Previously, Luke led collaborative and multi-stakeholder projects addressing foundational and practical issues in research ethics including social media use, clinical trial priority-setting, and has explored the ethical and regulatory parameters paying research participants. His written work has appeared in leading medical and bioethics journals, and frequently lectures on various issues surrounding research ethics and human participant protection. Luke holds a PhD in Philosophy with a concentration in Ethics from the University of Toronto and an MA in Religion from Yale Divinity School.

Latest Posts by Luke Gelinas

Clinical Research Trends to Expect in 2025: More Complex, Less Connected

Christine Senn digs into the results of Advarra’s Site-Sponsor-CRO Collaboration survey to reveal some new...

Read More...

A balancing act: Innovating IRBs for the future of pediatric oncology research

Advarra deep-dives into special considerations needed for high-quality and sensitive pediatric oncology trial IRB reviews.

Read More...

Balancing Innovation, Ethics, and Operational Excellence in Adaptive Oncology Trials

Balancing Innovation, Ethics, and Operational Excellence in Adaptive Oncology Trials Clinical trials are evolving to...

Read More...

Striking the Balance: Ethics, Inclusion, and Vulnerability in Research

Navigating research compliance often means addressing unseen challenges. Explore strategies to identify blind spots and...

Read More...

Best Practices for IRB Review of DCTs: Expert Perspectives

A variety of distinctive ethical, regulatory, and legal challenges stand in the way of greater...

Read More...

Improving Diversity in Clinical Trials: Strategies for Inclusive and Ethical Research

Clinical research aims to produce knowledge in the service of treating diseases and improving human...

Read More...

Evaluating Payment to Participate in Research: Ethical and Regulatory Issues

Navigating research compliance often means addressing unseen challenges. Explore strategies to identify blind spots and...

Read More...
Return of Research Results to Study Participants

Return of Research Results to Study Participants

Individuals invest a great deal to participate in clinical research, undertaking risks and burdens, while...

Read More...

Unique Ethical Issues in Phase I Oncology Studies

Phase I oncology trials present distinct ethical challenges, such as participant vulnerability and the risk...

Read More...

Maintaining Data & Reporting Integrity with Mobile Health

As the COVID-19 pandemic has forced a shift toward remote modalities, mobile health (mHealth) technologies...

Read More...

Research Equity and Enrolling Non-English Speakers

Informed consent, a cornerstone of ethical research, involves describing important elements of research in a...

Read More...

IRB Review of Phase I Research: Balancing Ethics and Efficiency

Phase I research demands careful IRB oversight, balancing participant safety with timely reviews. Proactive strategies...

Read More...
Scroll to Top